|国家科技期刊平台
首页|期刊导航|中国合理用药探索|益气固涩温脾汤加减辅助治疗结直肠癌根治术后吻合口瘘的临床研究

益气固涩温脾汤加减辅助治疗结直肠癌根治术后吻合口瘘的临床研究OA

Clinical Study on Modified Yiqiguse Wenpi Decoction in Adjuvant Treatment of Anastomotic Leakage after Radical Resection of Colorectal Cancer

中文摘要英文摘要

目的:探讨益气固涩温脾汤加减辅助治疗结直肠癌根治术后吻合口瘘患者的临床效果.方法:选取2022年1~12月期间某院收治的52例结直肠癌根治术后吻合口瘘患者作为研究对象,按照随机数字表法分为A组(n=24)和B组(n=28).A组患者给予注射用头孢西丁钠等单纯常规对症治疗,B组在A组基础上给予益气固涩温脾汤加减治疗,共持续治疗3周.比较两组患者吻合口瘘愈合时间、恢复正常饮食时间、住院时间、症状评分(吻合口浊液、腹部剧痛、纳差、排便不畅)、临床疗效及不良反应发生情况.结果:治疗后,B组患者吻合口瘘愈合时间、恢复正常饮食时间、住院时间均短于A组(P<0.05);两组患者吻合口浊液、腹部剧痛、纳差、排便不畅症状评分均降低(P<0.05),且B组低于A组(P<0.05);B组患者治疗总有效率(96.43%)高于A组(70.83%,P<0.05);两组患者不良反应发生率比较无统计学差异(P=0.541).结论:在单纯常规对症治疗基础上联合益气固涩温脾汤加减辅助治疗结直肠癌根治术后吻合口瘘患者临床疗效较好,可有效改善患者临床症状,降低症状评分,且未增加不良反应的发生风险.

Objective:To explore the clinical effect of modified Yiqiguse Wenpi decoction in the adjuvant treatment of anastomotic leakage after radical resection of colorectal cancer.Methods:52 patients with anastomotic leakage after radical resection of colorectal cancer,who were admitted to a certain hospital from January to December 2022,were divided into group A(n=24)and group B(n=28)by random number table method.The group A was treated with simple conventional symptomatic treatment such as cefoxitin sodium for injection,and the group B was treated with modified Yiqiguse Wenpi decoction in addition to the treatment given in the group A during the 3-week treatment.The healing time of anastomotic leakage,the time of recovery to normal diet,the length of hospital stay,symptom scores(anastomotic turbid fluid,severe abdominal pain,poor appetite,impaired bowel movement),clinical response and adverse reactions were compared between the two groups.Results:After treatment,the healing time of anastomotic leakage,the time of recovery to normal diet and the length of hospital stay in group B were shorter than those in the group A(P<0.05).The scores of anastomotic turbid fluid,severe abdominal pain,poor appetite and impaired bowel movement were decreased in both groups(P<0.05),and lower in the group B as compared with group A(P<0.05).The total response rate in group B(96.43%)was higher than that in group A(70.83%,P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P=0.541).Conclusion:The simple conventional symptomatic treatment combined with modified Yiqiguse Wenpi decoction in the adjuvant treatment of patients with anastomotic leakage after radical resection of colorectal cancer has demonstrated definite clinical efficacy,with effectively improved clinical symptoms and reduced symptom scores,without additional risks of adverse reactions.

原志男;朱广灿;高宗跃

河南省中医院普外科,郑州 450000河南省中医院肛肠科,郑州 450000

临床医学

益气固涩温脾汤结直肠癌根治术吻合口瘘临床疗效

Yiqiguse Wenpi decoctioncolorectal cancerradical resectionanastomotic leakageclinical efficacy

《中国合理用药探索》 2024 (003)

39-44 / 6

河南省中医药科学研究专项课题(2022ZY2027)

10.3969/j.issn.2096-3327.2024.03.007

评论